Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

G-rich DNA suppresses systemic lupus.

Prashant S Patole1, Daniel Zecher, Rahul D Pawar

  • 1Medical Policlinic, Ludwig-Maximilians-University Munich, Germany.

Journal of the American Society of Nephrology : JASN
|September 24, 2005
PubMed
Summary

Self DNA, specifically CpG motifs, can activate Toll-like receptor-9 (TLR-9), contributing to lupus nephritis. Blocking these CpG-DNA effects with G-rich DNA reduced disease severity and immune cell activation in mice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Frontiers in immunology·2026
Same author

Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays.

HLA·2026
Same author

A Prospective Multicenter Luminex-Based Clinical Algorithm to Define Unacceptable HLA Mismatches Before Kidney Transplantation. Consequences on Outcome, Waiting Time, and Wait List Composition.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Acute Rejection With DSA-Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04-Mismatch Successfully Stabilised With Daratumumab.

HLA·2026
Same author

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

The New England journal of medicine·2025
Same author

Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025

Area of Science:

  • Immunology
  • Molecular Biology
  • Nephrology

Background:

  • Immune complexes activate immune cells in kidney disease, but the role of DNA sequences is unclear.
  • Toll-like receptor-9 (TLR-9) recognizes microbial CpG-DNA, triggering immune responses.
  • Endogenous CpG-DNA may contribute to autoimmune diseases like lupus nephritis.

Purpose of the Study:

  • To investigate the role of endogenous CpG-DNA in lupus nephritis pathogenesis.
  • To determine if blocking CpG-DNA effects with G-rich DNA can ameliorate lupus nephritis in a mouse model.

Main Methods:

  • Used a synthetic G-rich DNA oligodeoxynucleotide to block CpG-DNA effects.
  • Administered G-rich DNA to MRL(lpr/lpr) mice with lupus nephritis.
  • Assessed immune cell proliferation, autoantibody production, and kidney/lung tissue injury.

Related Experiment Videos

Main Results:

  • G-rich DNA suppressed CpG-DNA-induced immune responses in vitro and in vivo.
  • G-rich DNA co-localized with glomerular immune complexes in lupus nephritis mice.
  • Treatment with G-rich DNA reduced lymphoproliferation, autoantibody levels, and tissue injury in MRL(lpr/lpr) mice.

Conclusions:

  • Adjuvant activity of self-DNA, via CpG motifs and TLR-9, contributes to lupus nephritis pathogenesis.
  • Modulating the CpG-DNA-TLR-9 pathway presents a potential therapeutic strategy for lupus nephritis.